Terkko Navigator / -/ Feeds / " ( ( Kasvaimen lääkeresistenssi )|( Syövän lääkeresistenssi )|( Tuumorin lääkeresi"

Cancers, Vol. 14, Pages 3111: Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells

Cancers, Vol. 14, Pages 3059: The Role of SLC7A11 in Cancer: Friend or Foe?

Cancers, Vol. 14, Pages 3062: Emergence of Resistance to MTI-101 Selects for a MET Genotype and Phenotype in EGFR Driven PC-9 and PTEN Deleted H446 Lung Cancer Cell Lines

Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors

Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors

Cancers, Vol. 14, Pages 3047: Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies

Healthcare, Vol. 10, Pages 1121: Antibiotic Resistance of Helicobacter pylori in Children with Gastritis and Peptic Ulcers in Mekong Delta, Vietnam

Cancers, Vol. 14, Pages 1807: Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant Brca1 Proficient and Deficient Murine Ovarian Cells

#58 Establishment of an antibiogram in paediatric Oncology unit in National Cancer Institute - Sri Lanka Samanmalee Gunasekara 1, Upeka Rathnayaka 1, Deepika Vidanage 1 1 Department of Microbiology, National Cancer Institute, Sri Lanka

CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer

Antibiotic Resistance Results of Helicobacter pylori in a University Hospital: Comparison of the Hybridization Test and Real-Time Polymerase Chain Reaction

High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study

Pharmaceutics, Vol. 13, Pages 1739: Non-Clinical In Vitro Evaluation of Antibiotic Resistance Gene-Free Plasmids Encoding Human or Murine IL-12 Intended for First-in-Human Clinical Study

Microorganisms, Vol. 10, Pages 322: Clinical Factors Implicated in Antibiotic Resistance in Helicobacter pylori Patients

Cancers, Vol. 14, Pages 1231: Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets

Cancers, Vol. 12, Pages 2518: Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma

Cancers, Vol. 12, Pages 2518: Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma

Cancers, Vol. 12, Pages 3368: Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma

Cancers, Vol. 13, Pages 328: The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death

Cancers, Vol. 12, Pages 2551: Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells

Cancers, Vol. 12, Pages 2551: Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells

Cancers, Vol. 13, Pages 4355: The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma

Cancers, Vol. 13, Pages 4820: Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance

Cancers, Vol. 14, Pages 2222: LPIN1 Induces Gefitinib Resistance in EGFR Inhibitor-Resistant Non-Small Cell Lung Cancer Cells

Cancers, Vol. 12, Pages 2358: Romo1 Inhibition Induces TRAIL-Mediated Apoptosis in Colorectal Cancer

Cancers, Vol. 12, Pages 2358: Romo1 Inhibition Induces TRAIL-Mediated Apoptosis in Colorectal Cancer

Cancers, Vol. 12, Pages 3675: Autophagy in Osteosarcoma Cancer Stem Cells Is Critical Process which Can Be Targeted by the Antipsychotic Drug Thioridazine

Cancers, Vol. 13, Pages 3210: Epigenetic Deregulation of Apoptosis in Cancers

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition

Cancers, Vol. 13, Pages 3324: Extracellular Vesicles as Mediators of Cancer Disease and as Nanosystems in Theranostic Applications

Cancers, Vol. 14, Pages 1089: State of the Art and Future Implications of SH003: Acting as a Therapeutic Anticancer Agent

Cancers, Vol. 14, Pages 2562: GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells

Cancers, Vol. 12, Pages 2583: Temozolomide-Induced RNA Interactome Uncovers Novel LncRNA Regulatory Loops in Glioblastoma

Cancers, Vol. 12, Pages 2583: Temozolomide-Induced RNA Interactome Uncovers Novel LncRNA Regulatory Loops in Glioblastoma

Drug addiction mutations unveil a methylation ceiling in EZH2-mutant lymphoma

Antibiotics, Vol. 9, Pages 580: A Significant Question in Cancer Risk and Therapy: Are Antibiotics Positive or Negative Effectors? Current Answers and Possible Alternatives

Cancers, Vol. 12, Pages 2482: Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells

Cancers, Vol. 12, Pages 2482: Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells

Cancers, Vol. 13, Pages 2878: Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies

Cancers, Vol. 13, Pages 4363: Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance

Cancers, Vol. 13, Pages 4631: Generation of Antibody-Drug Conjugate Resistant Models

Cancers, Vol. 13, Pages 5009: Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures

Cancers, Vol. 13, Pages 6385: PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword

Cancers, Vol. 14, Pages 2684: Pancreatic Cancer and Microenvironments: Implications of Anesthesia

Cancers, Vol. 12, Pages 2394: Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor

Cancers, Vol. 12, Pages 2394: Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor

Cancers, Vol. 12, Pages 3273: Pharmacotranscriptomic Analysis Reveals Novel Drugs and Gene Networks Regulating Ferroptosis in Cancer

Cancers, Vol. 12, Pages 3323: Mechanisms of Taxane Resistance

Cancers, Vol. 12, Pages 3323: Mechanisms of Taxane Resistance

Cancers, Vol. 12, Pages 3628: Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by Heterogenous Drug Uptake and Processing